首页>
外国专利>
USE OF IMMUNE CHECKPOINT MODULATORS IN COMBINATION WITH ANTIGEN-SPECIFIC T CELLS IN ADOPTIVE IMMUNOTHERAPY
USE OF IMMUNE CHECKPOINT MODULATORS IN COMBINATION WITH ANTIGEN-SPECIFIC T CELLS IN ADOPTIVE IMMUNOTHERAPY
展开▼
机译:免疫检查点调节剂与抗原特异性T细胞联合在适应性免疫治疗中的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
Provided herein are methods of treating a human patient, comprising administering to the human patient an inhibitory immune checkpoint inhibitor or stimulatory immune checkpoint activator and administering to the human patient a population of human cells comprising antigen-specific T cells that are derived from a T cell line restricted by a subdominant HLA allele or HLA allele combination. Also provided are methods of selecting such a T cell line and methods of selecting a T cell donor from whom to derive such a T cell line, for therapeutic administration to a human patient in combination with administration of an inhibitory immune checkpoint inhibitor or stimulatory immune checkpoint activator. Also provided are pharmaceutical compositions comprising an inhibitory immune checkpoint inhibitor or stimulatory immune checkpoint activator and a population of human cells comprising antigen- specific T cells that are derived from a T cell line restricted by a subdominant HLA allele or HLA allele combination.
展开▼